Israel Englander Compugen LTD Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Compugen LTD stock. As of the latest transaction made, Millennium Management LLC holds 395,748 shares of CGEN stock, worth $569,877. This represents 0.0% of its overall portfolio holdings.

Number of Shares

395,748

Previous 394,445 0.33%

Holding current value

$569,877

Previous $575,000 22.43%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.18 - $1.79 $1,537 - $2,332	1,303 Added 0.33%	395,748 $704,000
Q1 2025 May 15, 2025	BUY	$1.46 - $2.57 $51,170 - $90,073	35,048 Added 9.75%	394,445 $575,000
Q4 2024 Feb 14, 2025	BUY	$1.41 - $1.93 $221,312 - $302,930	156,959 Added 77.53%	359,397 $549,000
Q3 2024 Nov 14, 2024	BUY	$1.56 - $2.1 $234,569 - $315,766	150,365 Added 288.76%	202,438 $366,000
Q2 2024 Aug 14, 2024	SELL	$1.68 - $2.52 $592,604 - $888,907	-352,741 Reduced 87.14%	52,073 $87,000
Q1 2024 May 15, 2024	BUY	$1.75 - $2.95 $221,119 - $372,744	126,354 Added 45.38%	404,814 $1.04 Million
Q4 2023 Feb 14, 2024	BUY	$0.53 - $2.0 $147,583 - $556,920	278,460 New	278,460 $551,000
Q1 2023 May 15, 2023	BUY	$0.68 - $1.11 $36,222 - $59,128	53,269 Added 200.95%	79,777 $56,000
Q4 2022 Feb 14, 2023	SELL	$0.58 - $1.2 $397,776 - $822,985	-685,821 Reduced 96.28%	26,508 $19,000
Q3 2022 Nov 14, 2022	BUY	$0.66 - $2.32 $224,846 - $790,368	340,676 Added 91.67%	712,329 $468,000
Q2 2022 Aug 15, 2022	BUY	$1.57 - $3.33 $84,232 - $178,657	53,651 Added 16.87%	371,653 $688,000
Q1 2022 May 16, 2022	SELL	$2.76 - $4.64 $205,722 - $345,851	-74,537 Reduced 18.99%	318,002 $1.02 Million
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $1.21 Million - $2.12 Million	-295,641 Reduced 42.96%	392,539 $1.69 Million
Q1 2021 May 17, 2021	BUY	$7.67 - $13.77 $1.24 Million - $2.23 Million	161,651 Added 30.7%	688,180 $5.91 Million
Q4 2020 Feb 16, 2021	BUY	$12.07 - $17.95 $5.65 Million - $8.4 Million	467,775 Added 796.16%	526,529 $6.38 Million
Q3 2020 Nov 16, 2020	SELL	$14.16 - $19.45 $2.55 Million - $3.51 Million	-180,305 Reduced 75.42%	58,754 $955,000
Q2 2020 Aug 14, 2020	BUY	$6.97 - $17.12 $743,064 - $1.83 Million	106,609 Added 80.49%	239,059 $3.59 Million
Q1 2020 May 14, 2020	BUY	$5.79 - $11.83 $640,223 - $1.31 Million	110,574 Added 505.46%	132,450 $962,000
Q4 2019 Feb 14, 2020	BUY	$3.9 - $6.16 $23,926 - $37,791	6,135 Added 38.97%	21,876 $130,000
Q3 2019 Nov 14, 2019	SELL	$3.01 - $4.49 $11,320 - $16,886	-3,761 Reduced 19.29%	15,741 $66,000
Q2 2019 Aug 15, 2019	SELL	$2.8 - $4.14 $117,625 - $173,917	-42,009 Reduced 68.3%	19,502 $75,000
Q2 2019 Aug 14, 2019	BUY	$2.8 - $4.14 $172,230 - $254,655	61,511 New	61,511 $2.15 Million
Q1 2019 May 14, 2019	SELL	$2.35 - $4.19 $65,480 - $116,750	-27,864 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.17 - $3.8 $60,464 - $105,883	27,864 New	27,864 $60,000
Q3 2018 Nov 14, 2018	SELL	$3.0 - $4.05 $257,919 - $348,190	-85,973 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.15 - $4.7 $270,814 - $404,073	85,973 New	85,973 $284,000

Others Institutions Holding CGEN

# of Institutions

Shares Held

16.4M

Call Options Held

59.3K

Put Options Held

32.1K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $125M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account